Xoma reported $-4436000 in Pre-Tax Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agios Pharmaceuticals AGIO:US $ -84.26M 1.47M
Ardelyx ARDX:US $ 43.59M 88.77M
Bluebird Bio BLUE:US $ -216.93M 14.49M
Celldex Therapeutics CLDX:US $ -20.68M 7.31M
Chimerix CMRX:US $ -18.56M 0.8M
Curis CRIS:US $ -11.05M 0.21M
Eli Lilly And LLY:US $ 1470.5M 518.1M
Epizyme EPZM:US $ -65.83M 1.47M
Intercept Pharmaceuticals ICPT:US $ -3.63M 7.46M
Life Technologies LIFE:US $ -7.67M 2.72M
Macrogenics MGNX:US $ -52.89M 12.95M
Novartis NOVN:VX SF 4544M 120M
Novartis NVS:US $ 4544M 120M
Prothena PRTA:US $ 109.2M 81.3M
Regeneron Pharmaceuticals REGN:US $ 1822.2M 2076.1M
Teva Pharmaceutical Industries TEVA:US $ 807M 13M
Xoma XOMA:US $ -4.44M 2.2M